go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

Dokusys

Organization type
RDM medtech
Region
Lower Austria
Cluster
ecoplus
Topic
telemedicine and e-health
software for medicine
Details

LumiraDX GmbH

Organization type
RDM medtech
Region
Styria
Topic
telemedicine and e-health
software for medicine
Details

RobotDreams GmbH

Organization type
RDM medtech
Region
Styria
Cluster
Human.technology Styria
Details

W&H

Organization type
RDM medtech
Region
Salzburg
Cluster
Medical Technology Cluster
Topic
dental devices
single-use devices
resuable devices
Details

Contact



Contact: